| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/29/12 | UPLOAD | SEC-generated letter |
|
1 | |
| 03/28/12 | DEF 14A | Definitive proxy statements |
|
29 | |
| 03/15/12 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
   |
156 |
| 03/15/12 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
81 | |
| 03/13/12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
41 |
| 03/12/12 | UPLOAD | SEC-generated letter |
|
2 | |
| 01/31/12 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
79 | |
| 01/30/12 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
77 |
| 01/27/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 01/19/12 | 8-K | Current report filing |
|
85 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.